Overview

Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary goal of the study is to determine the best dose of an investigational drug to give to patients with multiple myeloma and to evaluate the investigational drug's effectiveness as a treatment for multiple myeloma.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer